MMGBSA interaction energies were computed. Druggability aspects were explored by calculating ADME related properties. A peptidomimetic compound has been strategically designed to introduce some druggability features in the peptide maintaining its viral template inhibition capability. Designed peptidomimetic lead compound may help in obtaining non toxic anti HIV agents in future. This is the first study to suggest a plausible explanation for the anti HIV activity of antifungal peptides at the molecular level and corroborate experimental findings of synergistic effects of these peptides on anti HIV agents.
Introduction
Antifungal agents are primarily used for the treatment and prevention of human fungal diseases like candidiasis, ring worm etcetra 1 . Antifungal agents are used topically, orally 2 as well as administered intravenously to treat severe systemic infections like cryptococcal meningitis 3 . Topical antifungal preparations usually do not cause any side effects. Oral antifungal drugs cause few common side effects like nausea, diarrhoea and headache 4 . However, the antifungals injected intravenously for severe internal infections, for example, Amphotericin B cause serious problems and are administered only when the need for treatment outweighs their risk 5 . The need for safe antifungals has increased multifold with rising number of AIDS patients and everyday increase in resistant strains of fungi.
AIDS patients suffer from poor immune system and are thus, at constant risk of developing internal fungal infection. Such patients are prescribed regular antifungal medications 6 . Long term antifungal medications obviously require safer drugs as compared to commonly prescribed azole compounds.
Many antimicrobial peptides (AMPs) have been isolated, tested, synthesized in search of safe, non toxic antifungals [7] [8] [9] [10] [11] . Some AMPs were found to be cytotoxic against mammalian cells 7 but few did not cause hemolysis of human erythrocytes and were considered safe for human use. While evaluating the antifungal property of some AMPs, they were observed to enhance the efficacy of anti HIV agents and were also suspected to be involved in inhibiting enzymes required for the replication of virus 12 . HIV virus inhibitory activities of some naturally occurring peptides have been collected in table 1 [13] [14] [15] [16] [17] .
The aim of this study is to explore the possibility of some AMPs inhibiting the viral transcription process by interacting with the viral RNA template, through interactions other than base pair-base pair type. Some natural AMPs classified as antifungal agents have been chosen for the study to achieve triple benefit of antifungal, anti HIV activities and cell permeability properties. This study D r a f t will provide a molecular level rationale for the observed anti HIV activity of some peptides. After understanding the mechanistic aspects, the study also aims to propose modifications in peptide structures to enhance their druggability. Peptide drugs in particular suffer from proteolytic problems and slow absorption due to their high molecular weights. Peptidomimetic compounds may thus emerge as better alternatives to treat severe systemic fungal infections and HIV infections simultaneously. 
Methodology

D r a f t
Docking studies
To study the interaction of chosen AMPs with the PBS of viral template and to judge its capability to block PBS, the peptide was now docked into the template choosing entire PBS as target. Grid was placed at the center of the template. Standard precision (SP) flexible ligand docking with post docking minimization was performed utilizing Glide module 25 of Schrodinger software. Best poses from SP docking were subjected to extra precision (XP) docking which is designed to weed out poses with unfavorable interactions and give a better correlation between good poses and good scores.
A maximum of 50 poses per ligand were subjected to post docking minimization out of which best 10 were filtered. For the studied peptides a maximum of three poses were generated in each case after post docking minimization. Since docking has been performed to a stretch of ssRNA as opposed to the binding pocket of any rigid protein it is prone to certain amount of uncertainty as the grid placement can also not be authenticated. To endorse the extra precision docking results we have performed accurate, large ab initio intermolecular interaction energy calculations on the best poses obtained. The best pose in each case sorted on Glide energy was then subjected to ab initio intermolecular interaction calculations at 6-31G basis set 26 
Calculation of druggability parameters and design of peptidomimetic lead compound
ADMET properties have been calculated utilizing QikProp module 30 . An AMP with the best interaction energy was then chosen and modified strategically to enhance druggability features to achieve a lead compound for the development of safer, non toxic antifungal agent with anti HIV activity in future.
Results and Discussion
Human immunodeficiency Modeled structures of chosen antifungal peptides were taken from protein databank and prepared for docking studies by adding hydrogen atoms and charges to atoms. The twisted conformations of these peptides used in docking studies are shown in fig. 2 . The anti HIV/ anti viral activity alongwith the antifungal activity of these peptides has been observed experimentally through cellular assays 31-34 but the mechanistic aspects still remain ambiguous at the molecular level. The PBS of ss viral RNA was taken from pdb file 4B3O corresponding to HIV-1RT ternary complex.
The phosphate backbone of viral PBS at the point of cleavage by RNase is discontinuous.
However, the entire PBS piece is intact and the conformation maintained as in its active position.
D r a f t
This is the latest pdb containing RNA/DNA hybrid. It contains the viral RNA PBS in catalytic conformation.
Now the prepared peptides were docked one by one to the viral template and the interactions were analyzed in detail. Fig. 3 fig. 4 . This peptide is more cationic as compared to Cm-p5. Its ab initio interaction energy is much more attractive as compared to Cm-p5. This peptide also obstructs the middle kink region of template in the vicinity of nuclease hydrolysis activity. Table 4 clearly indicates the cationic lysine residues of dermaseptin involved in hydrogen bonding with neighbouring bases on the template. Fig. 5 shows tachykinin anchored to template mainly through hydrogen bonding as it contains lesser number of cationic residues and therefore less electrostatic interaction. However, tachykinin can also inhibit the replication of virus as its conformation is appropriate to form non bonded interactions for anchorage. The closeup view in fig. 5b clearly shows the non bonded close contacts. After understanding the anti HIV activity of these peptides we computed their ADME properties to understand why these compounds have not succeeded clinically and what could possibly be the strategy to increase their druggability. Calculated ADME properties are given in table 5 which indicate that we need to drastically cut down on molecular weight, number of hydrogen bond donors and acceptors. Our systematic efforts to enhance druggability features are described in following section and shown schematically in Scheme II.
Since indolicidin gave the best binding energy, it seemed logical to start designing from there.
The first step was molecular weight reduction which was accomplished by mutating the noninteracting residues to glycine. Interacting residues were assessed from table 4. This led to significant decrease in molecular weight.
The mutated peptide labeled as 'Designed compound 1' was then prepared utilizing protein preparation wizard and docked into template to study its interaction. Docking results are shown in fig. 8 . Designed compound 1 shows significant interaction with template before and after solvation though the positive charge has been reduced. The ADME properties (c.f. fig. 9 . Designed compound 2 also shows interactions similar to designed compound 1. The coulombic contribution to binding energy has decreased due to less interacting -CH 2 NH-backbone. fig. 10 . Results of binding energy before and after solvation were similar to designed compound 2.
In brief, the designed peptidomimetic compounds although possess better druggability, they show binding energy weaker than natural peptide backbone. Also, when competing with primer for template show poor competitive inhibition. Compared to natural peptides which do show anti HIV activity 31-34 , designed compound 1 seems to be a good compromise between druggability and anti HIV activity. The encouraging aspect is that there is wide scope for development of a good, competitive peptidomimetic inhibitor of HIV-1RT. The mechanistic elucidation from this study will certainly help in this direction.
Concluding Remarks
In this study some natural, small antifungal peptides have been studied for their anti-HIV activity.
A possible mode of action for their viral inhibitory activity has been proposed. Efforts have been made to enhance druggability features of these peptides by mutating and introducing artificial backbone. Although the backbone alteration efforts were not so successful but this study is a preliminary step towards development of non toxic drugs for the combined treatment of two fatal diseases internal fungal infection and HIV infection. D r a f t 
